EUVIMEDOpdag EUVIMED
VergleichsstudieOpen access · CC BY 4.0

A Retrospective Comparison Between Home and in‐Office NB ‐ UVB Efficacy for Patients With Mycosis Fungoides

Victoria Garfinkel iD, Joan S Reisch, Heather Woodworth Goff iD

Photodermatology, Photoimmunology & Photomedicine · 2024

DOI: 10.1111/phpp.13009 ↗

At a glance

Vergleichsstudie in Photodermatology, Photoimmunology & Photomedicine, 2024. Written by Victoria Garfinkel and 2 co-authors. Institution: Medical School, University of Texas Southwestern Medical Center, Dallas, Texas, USA. Major MEDLINE topics: Mycosis Fungoides, Ultraviolet Therapy. Cited 1 times so far (Crossref); 22 references. The full text is freely available (open access, CC BY 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Introduction

This study addresses the gap in research comparing the effectiveness between home and in‐office narrowband ultraviolet B (NB‐UVB) phototherapy for the treatment of mycosis fungoides (MF). Elderly and disabled patients with this condition disproportionally lack access to home units due to insurance denial. Materials and Methods A retrospective review included patients diagnosed with MF or Sezary syndrome who underwent either in‐office or home UVB between 2016 and 2023. Eighty‐four patients used home NB‐UVB, while 75 used in‐office. Clinical characteristics, treatment response, and access were evaluated.

Results

Overall, there was no significant difference in response rates between home and in‐office NB‐UVB phototherapy. Subgroup analysis based on adjuvant treatment revealed a significant difference in clinical response rates for patients using NB‐UVB with topicals ( p = 0.008) and NB‐UVB with multiple systemic therapies ( p = 0.04). Financial and time constraints were the most common cause of treatment discontinuation for in‐office patients (28%).

Conclusions

The effectiveness of home NB‐UVB treatment is comparable, if not superior, to in‐office treatment, likely attributed to treatment ease in access and compliance. Medicare and other health insurance companies should expand coverage to include home‐based phototherapy for patients with MF, a potentially fatal cancer with a relative paucity of effective alternate therapies.

Subjects

MeSH terms (MEDLINE)

Mycosis FungoidesUltraviolet TherapyHumansMaleFemaleRetrospective StudiesMiddle AgedAgedAdultSkin NeoplasmsAged, 80 and over

Author keywords

efficacyhome‐based narrowband ultraviolet B phototherapymycosis Fungoides

Authors and institutions

  • Medical School, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Department of Biostatistics, Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.

ORCID profiles: Victoria Garfinkel, Heather Woodworth Goff

Cite

APA

Garfinkel, V., Reisch, J. S., & Goff, H. W. (2024). A Retrospective Comparison Between Home and in‐Office NB ‐ UVB Efficacy for Patients With Mycosis Fungoides. Photodermatology, Photoimmunology & Photomedicine. https://doi.org/10.1111/phpp.13009

Vancouver

Garfinkel V, Reisch JS, Goff HW. A Retrospective Comparison Between Home and in‐Office NB ‐ UVB Efficacy for Patients With Mycosis Fungoides. Photodermatology, Photoimmunology & Photomedicine. 2024. doi:10.1111/phpp.13009

BibTeX
@article{Garfinkel2024,
  author = {Garfinkel, Victoria and Reisch, Joan S and Goff, Heather Woodworth},
  title = {A Retrospective Comparison Between Home and in‐Office NB ‐ UVB Efficacy for Patients With Mycosis Fungoides},
  journal = {Photodermatology, Photoimmunology & Photomedicine},
  year = {2024},
  doi = {10.1111/phpp.13009}
}
Start for free →